1,562 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Croban

Croban bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,562 shares of the healthcare conglomerate's stock, valued at approximately $818,000.

Several other hedge funds also recently made changes to their positions in the business. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the 4th quarter valued at about $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group in the 4th quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group in the 4th quarter valued at about $30,000. Kapitalo Investimentos Ltda bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $41,000. Finally, Copia Wealth Management acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $42,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded up $4.30 during mid-day trading on Friday, hitting $303.81. 9,789,082 shares of the stock were exchanged, compared to its average volume of 7,687,343. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a 50-day simple moving average of $316.42 and a 200 day simple moving average of $442.28. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $275.60 billion, a P/E ratio of 12.72, a P/E/G ratio of 1.43 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the company earned $6.91 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.91%. UnitedHealth Group's dividend payout ratio is presently 37.02%.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer owned 679,493 shares of the company's stock, valued at $196,081,295.01. This represents a 14.63% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the company's stock in a transaction on Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director owned 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock valued at $31,607,768 in the last quarter. 0.28% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of brokerages recently weighed in on UNH. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a research note on Monday, May 19th. Morgan Stanley cut their target price on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Erste Group Bank lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. KeyCorp dropped their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. Finally, Baird R W downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average target price of $415.00.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.